EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NYSE Amex: AIS) today reported financial and operating results for the first quarter ended March 31, 2012. Quarter and Recent Highlights: Increased total revenue 92% and product revenue 78% to $6.9 million and $2.5 million, respectively, in the first quarter of 2012 compared to $3.6 million and $1.4 million, respectively, in the first quarter of 2011.
